Page last updated: 2024-12-06

kitazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

kitazine: see also record for kitazin P; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25834
SCHEMBL ID7174164
MeSH IDM0096063

Synonyms (37)

Synonym
5115-94-6
nsc49723
o,o-diethyl s-benzyl thiophosphate
13286-32-3
ricide
s-benzyl o,o-diethyl phosphorothioate
phosphorothioic acid,o-diethyl s-(phenylmethyl) ester
kitazin
wln: 2opo&o2&s1r
nsc-49723
o,o-diethyl s-benzyl phosphorothioate
s-benzyl-o,o-diethylester kyseliny thiofosforecne [czech]
kitazine
phosphorothioic acid, o,o-diethyl s-(phenylmethyl) ester
brn 2214893
nsc 49723
ritacin-p [russian]
phosphorothioic acid, s-benzyl o,o-diethyl ester
benzyl ethyl phosphorothioate ((phch2s)(eto)2po)
EBP ,
diethoxyphosphorylsulfanylmethylbenzene
4-06-00-02763 (beilstein handbook reference)
79bpy4n2dk ,
s-benzyl-o,o-diethylester kyseliny thiofosforecne
unii-79bpy4n2dk
ritacin-p
CCG-2098
AKOS015888420
SCHEMBL7174164
DTXSID0074502
sr-01000195999
SR-01000195999-1
isoprobenphos
diethyl (benzylsulfanyl)phosphonate
ebp;kitazin 48ec; nsc 49723;ricid
ebp (insecticide)
kitagine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.38 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]